Nucleix exhibited Bladder EpiCheck, best-in-class bladder cancer monitoring test, during the annual meeting of the Société Internationale d’Urologie (SIU). The SIU meeting is the world’s 3rd largest urology meeting that took place in Lisbon and included over 2,000 participants from around the world. During the meeting, Nucleix had created important relationships with urologists to promote the introduction of Bladder EpiCheck.